Jasper Therapeutics, Inc.
JSPR
$1.65
$0.074.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.27% | -45.62% | -23.23% | -10.55% | -3.98% |
| Total Depreciation and Amortization | -28.35% | 15.45% | 21.57% | 23.92% | 28.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.06% | 58.08% | 64.46% | 15.10% | -2.43% |
| Change in Net Operating Assets | 370.93% | 6,464.41% | -122.57% | -96.61% | -138.86% |
| Cash from Operations | -31.89% | -31.51% | -21.30% | -20.23% | -20.14% |
| Capital Expenditure | 84.99% | 8.50% | -98.12% | -106.74% | -476.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 89.65% | 16.26% | -89.10% | -99.25% | -476.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -26.64% | -86.31% | -98.88% | -53.02% | -53.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | 54.77% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -26.17% | -86.22% | -98.86% | -52.58% | -53.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -266.06% | -648.46% | -537.77% | -131.35% | -121.48% |